MCAL Therapeutics is a biotechnology company that develops treatment for ophthalmic diseases.
MCAL Therapeutics has raised $5.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
MCAL Therapeutics is headquartered in San Francisco, United States.
MCAL Therapeutics is a biotechnology company that develops treatment for ophthalmic diseases.
MCAL Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MCAL Therapeutics — Funding & Investors." VCBacked, March 27, 2024, https://www.vcbacked.co/company/mcal-therapeutics. Accessed August 18, 2026.
VCBacked. (2024). MCAL Therapeutics — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/mcal-therapeutics
{{cite web |title=MCAL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mcal-therapeutics |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated